SEC Form 4 · accession 0000886163-16-000178
LIGAND PHARMACEUTICALS INC · LGND
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Melanie J Herman
Officer — Director of Accounting
Period of report
May 18, 2016
Accepted (ET)
May 19, 2016 · 6:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000886163
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 18, 2016 | S | 334 | $120.50 | D | 3,297 | D |
Table II — derivative securities
No Table II lines on this filing.